PL4051251T3 - Stabilne, wolne od antyoksydantów roztwory noradrenaliny do wstrzykiwania - Google Patents
Stabilne, wolne od antyoksydantów roztwory noradrenaliny do wstrzykiwaniaInfo
- Publication number
- PL4051251T3 PL4051251T3 PL21783523.0T PL21783523T PL4051251T3 PL 4051251 T3 PL4051251 T3 PL 4051251T3 PL 21783523 T PL21783523 T PL 21783523T PL 4051251 T3 PL4051251 T3 PL 4051251T3
- Authority
- PL
- Poland
- Prior art keywords
- antioxidants
- stable
- solutions free
- noradrenaline
- injectable
- Prior art date
Links
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 title 1
- 239000003963 antioxidant agent Substances 0.000 title 1
- 229960002748 norepinephrine Drugs 0.000 title 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20203036 | 2020-10-21 | ||
| PCT/EP2021/076849 WO2022083993A1 (en) | 2020-10-21 | 2021-09-29 | Stable, injectable noradrenaline solutions free of antioxidants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4051251T3 true PL4051251T3 (pl) | 2024-04-08 |
Family
ID=73005396
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL21783523.0T PL4051251T3 (pl) | 2020-10-21 | 2021-09-29 | Stabilne, wolne od antyoksydantów roztwory noradrenaliny do wstrzykiwania |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230398070A1 (pl) |
| EP (1) | EP4051251B1 (pl) |
| AU (1) | AU2021366122A1 (pl) |
| CA (1) | CA3198908A1 (pl) |
| ES (1) | ES2959036T3 (pl) |
| IL (1) | IL302239B2 (pl) |
| PL (1) | PL4051251T3 (pl) |
| WO (1) | WO2022083993A1 (pl) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2832063B1 (fr) | 2001-11-15 | 2004-08-27 | Aguettant Lab | Procede de production de solutions stables de substances phenoliques et les solutions en resultant |
| UY35988A (es) | 2014-02-27 | 2015-09-30 | Sint Sa | Proceso para la producción de una solución inyectable de noradrenalina de baja concentración |
| PL2990031T3 (pl) | 2014-08-28 | 2020-05-18 | Sun Pharmaceutical Industries Ltd | Pozajelitowa postać norepinefryny |
| WO2018140894A1 (en) | 2017-01-30 | 2018-08-02 | Nevakar, Inc | Norepinephrine compositions and methods therefor |
| US10653646B2 (en) * | 2018-03-23 | 2020-05-19 | Nevakar Inc. | Epinephrine compositions and containers |
-
2021
- 2021-09-29 PL PL21783523.0T patent/PL4051251T3/pl unknown
- 2021-09-29 EP EP21783523.0A patent/EP4051251B1/en active Active
- 2021-09-29 AU AU2021366122A patent/AU2021366122A1/en active Pending
- 2021-09-29 CA CA3198908A patent/CA3198908A1/en active Pending
- 2021-09-29 ES ES21783523T patent/ES2959036T3/es active Active
- 2021-09-29 US US18/032,188 patent/US20230398070A1/en active Pending
- 2021-09-29 WO PCT/EP2021/076849 patent/WO2022083993A1/en unknown
-
2023
- 2023-04-19 IL IL302239A patent/IL302239B2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4051251C0 (en) | 2023-08-23 |
| ES2959036T3 (es) | 2024-02-19 |
| WO2022083993A1 (en) | 2022-04-28 |
| US20230398070A1 (en) | 2023-12-14 |
| IL302239B1 (en) | 2024-03-01 |
| IL302239A (en) | 2023-06-01 |
| AU2021366122A1 (en) | 2023-05-25 |
| EP4051251A1 (en) | 2022-09-07 |
| EP4051251B1 (en) | 2023-08-23 |
| IL302239B2 (en) | 2024-07-01 |
| CA3198908A1 (en) | 2022-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA204429S (en) | Case with earphones | |
| ZA202212237B (en) | Bark-free, stable dispersion | |
| PH12015502077A1 (en) | High purity lignin, lignin compositions, and higher structured lignin | |
| MX2018006148A (es) | Inhibidores de cxcr2. | |
| EP4369839A3 (en) | Wireless communication method and wireless communication terminal, which use discontinous channel | |
| MX2020003629A (es) | Produccion fermentativa de acido n-acetilneuraminico. | |
| EP3688366C0 (en) | LOW PROFILE CYLINDER BRACKET | |
| MX365329B (es) | Método para reticular ácido hialurónico; método para preparar un hidrogel inyectable; el hidrogel obtenido; el uso del hidrogel obtenido. | |
| MX2020004255A (es) | Compuesto de pirimidina como inhibidor de las janocinasas. | |
| EP3503636A4 (en) | METHOD FOR A TERMINAL FOR MAINTAINING UPLINK SYNCHRONIZATION AND TERMINAL | |
| BR112014028714A2 (pt) | método para configuração de uma rede sem fio | |
| EP3583223A4 (en) | HIGH PRESSURE ZONES FOR PRE-TREATMENT | |
| MX368883B (es) | Proceso nuevo para la eterificacion de las bis-resorcinil triazinas. | |
| GB202005709D0 (en) | Jar | |
| CA201356S (en) | Sconce | |
| MX2023009431A (es) | Metodo para crear un compuesto a base de mercurio, compuesto a base de mercurio, metodos de uso del compuesto a base de mercurio y usos del compuesto a base de mercurio. | |
| IL302239B2 (en) | Stable injectable norepinephrine solutions free of antioxidants | |
| GB202004975D0 (en) | Perforator | |
| DK4027026T3 (en) | Søm, særligt til anvendelse i et sømningsapparat | |
| CA203243S (en) | Case with earphones | |
| GB202103893D0 (en) | An electrolyser | |
| AR103779A1 (es) | Proceso para la producción de carbonato de calcio precipitado de alto contenido de sólidos con aditivo catiónico | |
| IN2015CH03069A (pl) | ||
| MX2020006271A (es) | Una composición antimicrobiana. | |
| MX2015009565A (es) | Proceso para elaborar derivados de magnolol. |